Axsome Therapeutics, Inc. (AXSM)
182.55
+1.71
(+0.95%)
USD |
NASDAQ |
Feb 06, 16:00
182.52
-0.03
(-0.02%)
After-Hours: 20:00
Axsome Therapeutics SG&A Expense (TTM) : 514.57M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Corcept Therapeutics, Inc. | 401.86M |
| Gilead Sciences, Inc. | 5.886B |
| Vanda Pharmaceuticals, Inc. | 214.26M |
| ACADIA Pharmaceuticals, Inc. | 523.36M |
| Amicus Therapeutics, Inc. | 353.07M |